TY  - GEN 
AU  - Díaz Villamarín, Xando
AU  - Piñar Morales, Raquel
AU  - Barrero Hernández, Francisco Javier
AU  - Antúnez Rodríguez, Alba
AU  - Cabeza Barrera, José
AU  - Morón Romero, María Rocío
PY  - 2022
UR  - https://hdl.handle.net/10481/77829
AB  - Multiple sclerosis is a chronic inflammatory neurological disease, and siponimod (Mayzent) is the first oral
treatment option for adult patients with secondary progressive multiple sclerosis. We performed a systematic
review of the pharmacogenetics...
LA  - eng
PB  - Elsevier
KW  - Multiple sclerosis
KW  - Pharmacogenetics
KW  - Siponimod
KW  - CYP2C9
KW  - Mayzent
TI  - Pharmacogenetics of siponimod: A systematic review
DO  - 10.1016/j.biopha.2022.113536
ER  -